TITLE

Pharmacotherapy for Obesity

AUTHOR(S)
Wong, Alex H.C.; Barg, Stefani S. N.; Leung, Alexander K. C.
PUB. DATE
January 2010
SOURCE
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery;Jan2010, Vol. 4 Issue 1, p47
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Obesity is at an epidemic level. All patients who are overweight and obese should be treated with diet, exercise, behavioral therapy or a combination thereof; however, these therapies may not be adequate for a number of patients. Pharmacotherapy should be considered for patients who are obese, are overweight with cardiovascular risk factors, or have failed standard therapy. Several medications, such as phentermine and diethylpropion for short-term treatment as well as sibutramine and orlistat for long-term treatment, are currently available. There are also off-label uses of other medications such as antidepressants, anticonvulsants, and anti-diabetic medications, for the management of obesity. All of these medications provide additional weight loss when used as an adjunct to the standard therapy of lifestyle modification. The objective of this review is to summarize different patents and new approaches in the treatment of obesity.
ACCESSION #
65217002

 

Related Articles

  • The 'Obesity Epidemic': An Alternative Perspective. Robison, Jon // Healthy Weight Journal;Jan/Feb2003, Vol. 17 Issue 1, p1 

    Focuses on the obesity epidemic in the U.S. as of January 2003. Action taken by the government to address the issue; Effects of war on obesity; Suggestions on a national action plan to tackle overweight and obesity.

  • Endoscopic Evaluation of Symptomatic Patients following Bariatric Surgery: A Literature Review. Subhani, Miral; Rizvon, Kaleem; Mustacchia, Paul // Diagnostic & Therapeutic Endoscopy;2012, p1 

    Obesity is an epidemic in our society, and rates continue to rise, along with comorbid conditions associated with obesity. Unfortunately, obesity remains refractory to behavioral and drug therapy but has shown response to bariatric surgery. Not only can long-term weight loss be achieved, but a...

  • Rising Burden of Obesity in Asia. Ramachandran, Ambady; Snehalatha, Chamukuttan // Journal of Obesity;2010, Vol. 2010, p1 

    Overweight and obesity have reached epidemic proportions in many Asian countries. These countries also face a grave burden of obesity-related disorders such as diabetes, hypertension, and cardiovascular diseases, which develop at a younger age than in Western populations. These disorders are...

  • Cardiovascular risk in the Asia–Pacific region from a nutrition and metabolic point of view: visceral obesity. Sullivan, David R // Asia Pacific Journal of Clinical Nutrition;Jun2001, Vol. 10 Issue 2, p82 

    The association between abdominal obesity and an increased risk of cardiovascular disease (CVD) is now well recognized. Both problems are becoming more prevalent within the Asia–Pacific region, but there are substantial differences within and between countries. The strength of the...

  • Obesity: Psychological and Behavioral Considerations. Tsai, Adam Gilden; Fabricatore, Anthony N. // American Family Physician;9/1/2006, Vol. 74 Issue 5, p867 

    The article discusses the psychological and behavioral considerations in treating obesity. In the evaluation and treatment of obesity, the National Heart, Lung, and Blood Institute guideline recommends that patients be provided with a comprehensive lifestyle program including dietary therapy,...

  • HOW HOT ARE YOU ON… OBESITY?  // Pulse;2/8/2007, Vol. 67 Issue 5, p58 

    The article presents questions and answers related to obesity. A reader asked on how does wait circumference influence clinical assessment of obesity. Another questioned the relationship between waist circumference, obesity and cardiovascular disease. Another person asked about visceral fat and...

  • Circulating ghrelin exists in both lipoprotein bound and free forms. Holmes, E.; Davies, I.; Lowe, G.; Ranganath, L. R. // Annals of Clinical Biochemistry;Nov2009, Vol. 46 Issue 6, p514 

    Introduction: Ghrelin is a gastric peptide that has been implicated in the development of obesity and cardiovascular disease. It has been reported that ghrelin binds to lipoproteins, although the different binding patterns of acylated ghrelin (AG) and unacylated ghrelin (UAG) are still to be...

  • Dietary factors and cancer chemoprevention: An overview of obesity-related malignancies. Murthy, N. S.; Mukherjee, S.; Ray, G.; Ray, A. // Journal of Postgraduate Medicine;Jan-Mar2009, Vol. 55 Issue 1, p45 

    Obesity is a growing health problem in developed nations and in countries that are in the process of westernization like India. Obesity is linked with several health disorders such as hypertension and cardiovascular diseases, Type 2 diabetes, dyslipidemia and certain cancers. Currently,...

  • Anthropometry measures and prevalence of obesity in the urban adult population of Cameroon: an update from the Cameroon Burden of Diabetes Baseline Survey. Kamadjeu, Raoul M.; Edwards, Richard; Atanga, Joseph S.; Kiawi, Emmanuel C.; Unwin, Nigel; Mbanya, Jean-Claude // BMC Public Health;2006, Vol. 6 Issue 1, p228 

    Background: The objective of the study was to provide baseline and reference data on the prevalence and distribution of overweight and obesity, using different anthropometric measurements in adult urban populations in Cameroon. Methods: The Cameroon Burden of Diabetes Baseline Survey was a...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics